Astrazeneca Phar

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE203A01020
  • NSEID: ASTRAZEN
  • BSEID: 506820
INR
8,429.00
139.15 (1.68%)
BSENSE

Mar 25

BSE+NSE Vol: 5.71 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryAstrazeneca Phar VS Pharmaceuticals & Biotechnology
 
1D
1.68%
1.63%
1W
-0.79%
-1.87%
1M
-4.44%
-8.51%
YTD
-6.45%
-11.67%
1Y
0.01%
-3.52%
3Y
150.43%
30.85%
5Y
170.83%
55.39%
10Y
621.82%
197.08%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.39%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-8.01%
0%
-8.01%
6 Months
-6.67%
0%
-6.67%
1 Year
0.01%
0.38%
0.39%
2 Years
64.28%
1.09%
65.37%
3 Years
150.43%
2.21%
152.64%
4 Years
222.61%
2.91%
225.52%
5 Years
170.83%
1.91%
172.74%

Latest dividend: 32 per share ex-dividend date: Jul-18-2025

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

Astrazeneca Pharma India Ltd has not been a consistent performer in the last 1 year and longer periods

3
Quartile
quartile-3
QTD
-6.6%
3
Quartile
quartile-3
Sep-Dec
-1.18%
2
Quartile
quartile-2
Jun-Sep
2.53%
4
Quartile
quartile-4
1Y
0.44%
1
Quartile
quartile-1
2025
22.84%
3
Quartile
quartile-3
2024
32.88%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

Astrazeneca Pharma India Ltd has not been a consistent performer in the last 1 year and longer periods

2
Quartile
quartile-2
QTD
-6.6%
2
Quartile
quartile-2
Sep-Dec
-1.18%
1
Quartile
quartile-1
Jun-Sep
2.53%
2
Quartile
quartile-2
1Y
0.44%
1
Quartile
quartile-1
2025
22.84%
3
Quartile
quartile-3
2024
32.88%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Good Performer

Astrazeneca Pharma India Ltd has been in the First and Second Quartile in the last 1 year and longer periods

2
Quartile
quartile-2
QTD
-6.6%
2
Quartile
quartile-2
Sep-Dec
-1.18%
2
Quartile
quartile-2
Jun-Sep
2.53%
2
Quartile
quartile-2
1Y
0.44%
1
Quartile
quartile-1
2025
22.84%
2
Quartile
quartile-2
2024
32.88%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s India SENSEX
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available